misonidazole has been researched along with Bone Cancer in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ametamey, SM; Arlt, MJ; Born, W; Brennecke, P; Campanile, C; Fischer, CR; Fuchs, B; Gvozdenovic, A; Honer, M; Krämer, SD; Müller, A; Sabile, AA; Schibli, R | 1 |
Bradley, KM; Fenwick, JD; Gleeson, FV; Higgins, GS; Macpherson, RE; McGowan, DR | 1 |
Brustad, T; Rofstad, EK | 1 |
Bataini, JP; Bernier, J; Brugère, J; Brunin, F; de Narbonne, J; Jaulerry, C | 1 |
Grierson, JR; Grunbaum, Z; Koh, WJ; Krohn, KA; Rasey, JS | 1 |
Glatstein, E; Kinsella, TJ | 1 |
1 trial(s) available for misonidazole and Bone Cancer
Article | Year |
---|---|
[Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
Topics: Bone Neoplasms; Clinical Trials as Topic; Glioma; Humans; Kinetics; Misonidazole; Neoplasms; Nitroimidazoles; Otorhinolaryngologic Diseases; Sarcoma | 1978 |
5 other study(ies) available for misonidazole and Bone Cancer
Article | Year |
---|---|
Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Fluorides; Fluorodeoxyglucose F18; Humans; Mice; Misonidazole; Osteoblasts; Osteoclasts; Osteosarcoma; Phenotype; Positron-Emission Tomography; Tibia | 2013 |
18F-Misonidazole PET-CT scan detection of occult bone metastasis.
Topics: Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Diagnosis, Differential; Humans; Lung Neoplasms; Male; Misonidazole; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Radiosensitizing effect of misonidazole in acute and fractionated irradiation of a human osteosarcoma xenograft.
Topics: Adolescent; Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Humans; Male; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Osteosarcoma; Transplantation, Heterologous | 1980 |
Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.
Topics: Adenocarcinoma; Animals; Bone Neoplasms; Cell Hypoxia; Cells, Cultured; Contrast Media; Cricetinae; Cricetulus; Dogs; Fibroblasts; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Osteosarcoma; Radiation Tolerance; Radionuclide Imaging; Sarcoma, Experimental | 1989 |
Clinical experience with intravenous radiosensitizers in unresectable sarcomas.
Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Neoplasms; Bromodeoxyuridine; Female; Humans; Injections, Intravenous; Male; Middle Aged; Misonidazole; Radiation Dosage; Radiation-Sensitizing Agents; Sarcoma | 1987 |